Modular Medical Prices 750,000-Share Offering to Raise $3.4M
Modular Medical is selling 750,000 common shares at $4.50 to raise $3.4 million in a registered direct offering, expected to close on or about April 21, 2026 before fees and expenses. Maxim Group LLC serves as sole placement agent under the effective shelf registration statement.
1. Offering Terms
Modular Medical announced a registered direct offering of 750,000 common shares priced at $4.50 per share, generating estimated gross proceeds of $3.4 million before placement agent fees and offering expenses.
2. Closing Conditions and Process
The offering is expected to close on or about April 21, 2026, subject to customary closing conditions, with Maxim Group LLC acting as sole placement agent under a Form S-3 shelf registration declared effective on May 22, 2025.
3. Company Overview
Modular Medical is a medical device company developing patient-centric insulin delivery technologies using patented microfluidics engineering. The company seeks to combine efficacy with affordability to broaden access to advanced glycemic control beyond specialist users.